G. Walmsley Graham, Director at Akero Therapeutics, Inc. (AKRO), bought 150,000 shares at $19.85 ($3.0M) on 2023-12-08, disclosed to the SEC on 2023-12-11.
Open-market purchase of $3.0M AKRO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.80 | 50,000 | $990K | 33.3% |
| 2 | $19.85 | 50,000 | $993K | 33.4% |
| 3 | $19.85 | 50,000 | $993K | 33.4% |
| Total | $19.83 avg | 150,000 | $3.0M | 100% |
| Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |